top of page
Search

Mitsubishi Gas Chemical Invests in Whitespace Enterprises to Accelerate Medical Business Development

Arcterus

Read Mitsubishi's official press release here.


Mitsubishi Gas Chemical Company, Inc. (MGC; Head Office: Chiyoda-ku, Tokyo; President: Toshikiyo Kurai) has invested in three companies engaging in medical business development.


In recent years, medical industry is paying increasing attention to sophisticated technologies that improve the quality of medical care and quality of life. For example, rapid diagnosis facilitates for early treatment/care, while regenerative medicine makes it possible to eliminate the very cause of the disease or injury in question by reproducing tissues and organs using cells and tissues cultured in vitro. The market for such techniques is expected to grow rapidly in the future.


Precise forming technology is required to reduce the size and increase the functionality of test/diagnosis devices used for rapid diagnosis. Expecting to fully leverage its chemical and material expertise in this field, MGC is investing in CONSONAL BIOTECHNOLOGIES Co., Ltd., Japan's largest comprehensive research institution “RIKEN” certified venture, and WhiteSpace Enterprise Corporation, a venture created from innovation at the University of Arizona to conduct research and development of biomolecular technologies with a view to entering the market in the future.


Also, MGC’s investment in NC Medical Research, Inc., a research and development specialist in regenerative medicine, is to survey opportunities to create a business using MGC technology in the field.


Under its Medium-term Management Plan “MGC Advance2020”, MGC defines the medical/food field as one of five target fields of business to focus on. In connection with medical, MGC has a broad range of products and technologies including oxygen absorbers for medicine and medical equipment, multilayered plastic containers for medical use, and techniques related to antibody and nucleic acid medicines. The investments in the three companies will help MGC develop its medical/food field even further


WHITESPACE ENTERPRISE

Corporation Company name: WHITESPACE ENTERPRISE

Corporation Location: 1305 W Auto Drive Tempe, AZ 85284, USA

Business description: Commercialization of technologies developed by the University of Arizona and other institutions, including disease diagnosis devices and small automatic processing equipment

Established: 2007 Capital: 15.8 million US dollars Investment:


March 2018 Purpose: Establish joint development to jointly enter the market for medical test equipment Remarks: MGC will conclude a joint research agreement with the University of Arizona, the founder and technical advisor of WSE, under which MGC researchers will be sent to the laboratory of Professor Frederic Zenhausern. Website: http://wsecorp.com/

31 views0 comments

留言


  • Facebook
  • Twitter
  • LinkedIn

©2020 by ARCTERUS.

bottom of page